Amlodipine Besylate Tablet
Product Images NDC 65841-621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 65841-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 04

89ddd1bc 9088 4204 8554 D25848ae6b16 04
This is a description of medication, commonly known as Amlodipine Besylate, with a strength of 2.5 mg. The package contains 90 tablets that should be stored at room temperature between 20 and 25°C. The medicine should be dispensed in a light-resistant container and is manufactured by Zydus, a company based in India. The NDC number for this medication is 65841-620-16.*
FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 05

89ddd1bc 9088 4204 8554 D25848ae6b16 05
This is a drug label for Amlodipine Besylate tablets, used to treat high blood pressure and angina. The label provides information on the strength and dosage of the tablets along with storage conditions. It also includes a warning to keep the medication out of reach of children. The tablets should be stored in a light-resistant container at a temperature between 20°-25°C.*
FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 06

89ddd1bc 9088 4204 8554 D25848ae6b16 06
This text provides information on Amlodipine Besylate tablets. It includes dosage and storage instructions, as well as cautionary statements about keeping the drug out of reach of children and protecting it from light. The manufacturer is identified as Zydus.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.